CD4 and cancer: Silencing AGPAT4 releases lysophosphatidic acid from cancer cells, polarizing macrophages to an M1‐like phenotype, which promotes CD4+ and CD8+ T cell infiltration and activation, influencing colorectal cancer progression [63].